CRONOS GROUP INC. ANNOUNCES FIRST QUARTER 2018 RESULTS Q1 2018 total sales of $2.9 million, up 473% year over year Cannabis oil sales represent 29% of domestic medical patient...
Cronos Group Inc. Announces Fourth Quarter and Fiscal Year 2017 Results Q4 2017 sales of $1.6 million, up 274% year over year FY 2017 sales of $4.1 million, up 636% year...
With Canadian licensed producers under intense selling pressure over the past several weeks, insiders stepped up at three licensed producers, making large purchases over the past week or so...
Cronos Group Announces Closing of Previously Announced $100 Million Bought Deal TORONTO, April 6, 2018 /PRNewswire/ – Cronos Group Inc. (NASDAQ, TSX-V: CRON) (“Cronos Group” or the “Company”) is...
After a massive 17.7% decline in February, the Canadian Cannabis LP Index recovered just some of the losses in March, rallying 0.8% after having been up more than 13% earlier in...
After the close, Cronos Group (TSXV: CRON) (NASDAQ: CRON) filed a Form F-10 with the SEC, indicating that it is planning to sell shares in the United States in...
Cannabis Giants Join Forces in Cross Border Venture TORONTO, March 19, 2018 /CNW/ – Cronos Group Inc. (Nasdaq: CRON) (TSX-V: CRON) (“Cronos” or the “Company”) – With Canada on...
Cannabis stocks, as measured by the Global Cannabis Stock Index, plunged in February, more than reversing out the 10.7% gains in January by falling 26.7% to 115.33: The index,...
After a strong start to the year, with the Canadian Cannabis LP Index rising 17.7% in January, the benchmark reversed out the gains in February, declining 18.6% to leave...
Cronos Group to Begin Trading on Nasdaq Stock Exchange TORONTO, Feb. 26, 2018 /CNW/ – Cronos Group Inc. (TSX-V: MJN) (OTC Nasdaq Int’l Designation: PRMCF) (“Cronos Group” or the...
